Ticarcillin/clavulanic acid
              < Ticarcillin 
 
            
          | Combination of | |
|---|---|
| Ticarcillin | β-lactam antibiotic | 
| Clavulanic acid | β-lactamase inhibitor | 
| Clinical data | |
| Trade names | Timentin | 
| Routes of administration | Injection | 
| Legal status | |
| Legal status | 
 | 
| Identifiers | |
| CAS Number | |
Ticarcillin/clavulanic acid, or co-ticarclav, is a combination antibiotic consisting of ticarcillin, a β-lactam antibiotic, and clavulanic acid, a β-lactamase inhibitor. This combination results in an antibiotic with an increased spectrum of action and restored efficacy against ticarcillin-resistant bacteria that produce certain β-lactamases.